Edgewise Therapeutics (EWTX) News Today $14.86 +0.00 (+0.01%) As of 10:26 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EWTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Braidwell LP Has $54.09 Million Position in Edgewise Therapeutics, Inc. $EWTX3 hours ago | marketbeat.comWellington Management Group LLP Sells 89,590 Shares of Edgewise Therapeutics, Inc. $EWTXSeptember 2 at 4:11 AM | marketbeat.comDriehaus Capital Management LLC Trims Stock Holdings in Edgewise Therapeutics, Inc. $EWTXSeptember 1 at 5:36 AM | marketbeat.comEdgewise Therapeutics, Inc. $EWTX Shares Acquired by Siren L.L.C.August 31 at 6:29 AM | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Insider Sells $1,460,000.00 in StockAugust 29, 2025 | insidertrades.comNuveen LLC Buys New Position in Edgewise Therapeutics, Inc. $EWTXAugust 29, 2025 | marketbeat.comAnalysts Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Price Target at $40.55August 27, 2025 | americanbankingnews.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Average Rating of "Moderate Buy" by AnalystsAugust 26, 2025 | marketbeat.comCandriam S.C.A. Decreases Position in Edgewise Therapeutics, Inc. $EWTXAugust 25, 2025 | marketbeat.comVanguard Group Inc. Has $94.48 Million Holdings in Edgewise Therapeutics, Inc. $EWTXAugust 25, 2025 | marketbeat.comAberdeen Group plc Buys 134,982 Shares of Edgewise Therapeutics, Inc. $EWTXAugust 23, 2025 | marketbeat.comJPMorgan Chase & Co. Issues Pessimistic Forecast for Edgewise Therapeutics (NASDAQ:EWTX) Stock PriceAugust 21, 2025 | marketbeat.comJPMorgan cuts Edgewise target, remains from Analyst Focus ListAugust 20, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXAugust 17, 2025 | globenewswire.comDeutsche Bank AG Has $8.27 Million Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)August 17, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) CFO R Michael Carruthers Sells 1,428 SharesAugust 16, 2025 | marketbeat.comInsider Selling: Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Insider Sells 1,907 Shares of StockAugust 16, 2025 | marketbeat.comInsider Selling: Edgewise Therapeutics, Inc. (NASDAQ:EWTX) General Counsel Sells 2,098 Shares of StockAugust 16, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) CMO Sells $38,322.18 in StockAugust 16, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) CEO Kevin Koch Sells 7,972 SharesAugust 16, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXAugust 16, 2025 | prnewswire.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) CFO Sells $19,120.92 in StockAugust 15, 2025 | insidertrades.comEdgewise Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law FirmAugust 14, 2025 | gurufocus.comEdgewise Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law FirmAugust 14, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXAugust 13, 2025 | globenewswire.comResearch Analysts Offer Predictions for EWTX FY2029 EarningsAugust 12, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXAugust 11, 2025 | prnewswire.comEdgewise Therapeutics (NASDAQ:EWTX) Given New $49.00 Price Target at Royal Bank Of CanadaAugust 10, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXAugust 9, 2025 | globenewswire.comWe're Not Very Worried About Edgewise Therapeutics' (NASDAQ:EWTX) Cash Burn RateAugust 8, 2025 | finance.yahoo.comEdgewise Therapeutics Advances in Muscular Dystrophy TrialsAugust 8, 2025 | tipranks.comEdgewise Therapeutics shares surge as Q2 loss narrows, beats estimatesAugust 7, 2025 | za.investing.comEdgewise Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business HighlightsAugust 7, 2025 | prnewswire.comEdgewise Therapeutics (EWTX) to Release Earnings on ThursdayAugust 7, 2025 | marketbeat.comEdgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing RulesAugust 6, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXAugust 6, 2025 | prnewswire.comEdgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.9% - Here's WhyAugust 5, 2025 | marketbeat.comTD Asset Management Inc Invests $730,000 in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)August 5, 2025 | marketbeat.comRaymond James Initiates Strong Buy on Edgewise Therapeutics (EWTX) with $46 PT, Cites EDG-7500 Potential for HCMAugust 1, 2025 | insidermonkey.comEdgewise Therapeutics (NASDAQ:EWTX) Trading Up 8.3% - Time to Buy?July 31, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 31, 2025 | prnewswire.comEdgewise Therapeutics (NASDAQ:EWTX) Now Covered by Analysts at Raymond James FinancialJuly 31, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Takes $827,000 Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)July 30, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Rating of "Moderate Buy" by BrokeragesJuly 30, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 28, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 27, 2025 | prnewswire.comReadystate Asset Management LP Boosts Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)July 22, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 22, 2025 | prnewswire.comJennison Associates LLC Purchases New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)July 22, 2025 | marketbeat.comEdgewise Therapeutics Inc (EWTX) - Investing.comJuly 20, 2025 | investing.com Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EWTX Media Mentions By Week EWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EWTX News Sentiment▼1.210.96▲Average Medical News Sentiment EWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EWTX Articles This Week▼77▲EWTX Articles Average Week Get the Latest News and Ratings for EWTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Edgewise Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Avidity Biosciences News Today Nuvalent News Today Merus News Today CRISPR Therapeutics News Today TG Therapeutics News Today ACADIA Pharmaceuticals News Today Krystal Biotech News Today Cytokinetics News Today Jyong Biotech News Today ADMA Biologics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EWTX) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EWTX Stock Alerts